Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. (FNCH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fnch · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Finch Therapeutics Group, Inc. (FNCH) measures how much investors pay for each dollar of the company's trailing earnings. FNCH's current PE ratio of N/A is calculated by dividing its stock price of $7.45 by its TTM earnings per share of -$8.64.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2019 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Finch Therapeutics Group, Inc.You FNCH | $12M | N/A | — | -$8.64 |
 Bonus BioGroup Ltd. BBIXF | $152M | N/A | — | -$0.04 |
 Celyad Oncology S.A. CLYYF | $11M | 6.58x | — | $0.02 |
 Charlotte's Web Holdings, Inc. CWBHF | $67M | N/A | — | -$0.19 |
 EvoNext Holdings S.A. ELVAF | $8M | N/A | — | -$0.09 |
 MediPharm Labs Corp. MEDIF | $22M | N/A | — | -$0.02 |
 Institute of Biomedical Research Corp. MRES | $4M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-8.64 | — | |
2023-12-31 FY2023 | — | $-46.59 | — | |
2022-12-31 FY2022 | — | $-72.12 | — | |
2021-12-31 FY2021 | — | $-36.72 | — | |
2020-12-31 FY2020 | — | $-24.39 | — | |
2019-12-31 FY2019 | — | $-12.90 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Finch Therapeutics Group, Inc. (FNCH) measures how much investors pay for each dollar of the company's trailing earnings. FNCH's current PE ratio of N/A is calculated by dividing its stock price of $7.45 by its TTM earnings per share of -$8.64.
Frequently asked questions
FNCH pe ratio · 6 questionsFNCH's current PE ratio is N/A as of 2026-06-09, based on a stock price of $7.45 and TTM EPS of -$8.64. Data sourced from Financial Modeling Prep via FNCH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Finch Therapeutics Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09